| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |